References
- HU Y., SUN J., DAI Z., DENG H., LI X., HUANG Q., et al. Prevalence and severity of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol. 2020;127:104371.
- RUSLIE RH., DARMADI D., SIREGAR GA. Susceptibility of coronavirus disease-19 in pediatric population. Open Access Maced J Med Sci. 2020;8: 363–5.
- RAHMAN S., MONTERO MTV., ROWE K., KIRTON R., KUNIK JR F. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol. 2021;14(5):601–21.
- RUSLIE RH., DARMADI D., SIREGAR GA. Pediatric immunization practice during coronavirus disease-2019 pandemic. Open Access Maced J Med Sci. 2020;8: 258–60.
- TONG-MINH K., VAN DER DOES Y., ENGELEN S., DE JONG E., RAMAKERS C., GOMMERS D., et al. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department. BMC Infect Dis. 2022;22(1):165.
- World Health Organization. WHO coronavirus (COVID-19) dashboard. Available from: covid19.who.int. Accessed 6 October 2022.
- ZHANG N., XIE T., NING W., HE R., ZHU B., MAO Y. The severity of COVID-19 and its determinants: a systematic review and meta-analysis in China. Sustainability. 2021;13(9):5305.
- GHAHRAMANI S., TABRIZI R., LANKARANI KB., KASHANI SMA., REZAEI S., ZEIDI N., et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020;25(1):30.
- LAMERSs MM., HAAGMANS BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022;20(5):270–84.
- RUSLIE RH., DARMADI D. Coronavirus disease-2019 and mental health. Open Access Maced J Med Sci. 2020;8: 268–71.
- PONTI G., MACCAFERRI M., RUINI C., TOMASI A., OZBEN T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57(6):389–99.
- ZENG F., HUANG Y., GUO Y., YIN M., CHEN X., XIAO L., et al. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int J Infect Dis. 2020;96:467–74.
- SOLE FD., FARCOMENI S., LOFFREDO L., CARNEVALE R., MENICHELLI D., VICARIO T., et al. Features of severe COVID-19: a systematic review and meta-analysis. Eur J Clin Invest. 2020;50(10):e13378.
- AHMEIDI AA., MUSA A., AHMED HS., ELAHMAR AA., GOOTA RB., AHMED IA., et al. Inflammatory markers as predictors of mortality in COVID-19 infection. Afr J Lab Med. 2020;9(1):a1298.
- CARPENE G., NEGRINI D., HENRY BM., MONTAGNANA M., LIPPI G. Homocysteine in coronavirus disease (COVID-19): a systematic literature review. Diagnosis (Berl). 2022;9(3):306–10.
- HUANG I., PRANATA R., LIM MA., OEHADIAN A., ALISJAHBANA B. C-reactive protein, procalcitonin, D-dimer, and feritin in severe coronavirus disease-2019: a meta analysis. Ther Adv Respir Dis. 2020;14:1753466620937175.
- KHEDAR RS., GUPTA R., SHARMA KK., MITTAL K., AMBALIYA HC., GUPTA JB., et al. Biomarkers and outcomes in hospitalized covid-19 patients: a prospective registry. medRxiv. 2022;20:22277718.
- KESKIN A., USTUN GU., ACI R., DURAN U. Homocysteine as a marker for predicting disease severity in patients with COVID-19. Biomark Med. 2022;16(7):559–68.
- PONTI G., PASTORINO L., MANFREDINI M., OZBEN T., OLIVIA G., KALECI S., et al. COVID-19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalence. J Clin Lab Anal. 2021;35(7):e23798.
- DARMADI D., PAKPAHAN C., RUSLIE RH., REZANO A. Inflammatory laboratory findings associated with severe illness among hospitalized individuals with COVID-19 in Medan, Indonesia: a cross-sectional study. F1000Res. 2021; 10: 1246.
- HEIDARI-BENI F., VAHEDIAN-AZIMI A., SHOJAEI S., RAHIMI-BASHAR F., SHARIARY A., JOHNSTON TP., et al. The level of procalcitonin in severe COVID-19 patients: a systematic review and meta-analysis. Adv Exp Med Biol. 2021;1321:277–86.
- HEER RS., MANDAL AKJ., SZAWARSKI P., MISSOURIS CG. Procalcitonin is a biomarker for disease severity rather than bacterial co-infection in COVID-19. Eur J Emerg Med. 2022;29(4):315.